Combat Methamphetamine Enhancement Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
95pct
216d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (17)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA
Client expense: $1,902,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA
Client expense: $1,129,000 · Firm income: Not reported
HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA
Client expense: $1,631,812 · Firm income: Not reported
HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA
Client expense: $1,918,136 · Firm income: Not reported
HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA
Client expense: $1,650,000 · Firm income: Not reported
| Democratic |
| NY |
| Chuck Grassley | Republican | IA |
| Claire McCaskill | Democratic | MO |
| Evan Bayh | Democratic | IN |
| Harry Reid | Democratic | NV |
| James M. Inhofe | Republican | OK |
| Jeff Bingaman | Democratic | NM |
| John Ensign | Republican | NV |
| John F. Kerry | Democratic | MA |
| Jon Kyl | Republican | AZ |
| Lamar Alexander | Republican | TN |
| Maria Cantwell | Democratic | WA |
| Mark L. Pryor | Democratic | AR |
| Mitch McConnell | Republican | KY |
| Patty Murray | Democratic | WA |
| Richard J. Durbin | Democratic | IL |
| Tim Johnson | Democratic | SD |
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA
Client expense: $1,000,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA
Client expense: $1,000,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Bankruptcy
Draft bankruptcy technical corrections bill proposing partial repeal of bankruptcy attorney liability provisions contained in Sections 102, 203(a), and 226-229 of P.L. 109-8 (formerly S. 256), Bankruptcy Abuse Prevention and Consumer Protection Act of 2005, to add a new partnership section to the Bankruptcy Code, and to make certain technical amendments to Section 363(f) of the Code regarding certain sales of real property P.L. 111-327 (formerly, H.R. 6198) the Bankruptcy Technical Corrections Act
Client expense: $235,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Deposit Insurance Corporation (FDIC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Legal Services Corporation, Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2010 · fourth_quarter · Alcohol and Drug Abuse
HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals
Client expense: $715,571 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Office of Natl Drug Control Policy (NDCP), SENATE, Treasury, Dept of
2010 · fourth_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal (S. 3397, H.R. 5809) PDMP Funding/NASPER reauthorization (H.R. 5710) Drug Safety Enhancement Act (H.R. 6543)
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 415, the "Fallen Heros Flag Act," would provide the families of deceased public safety officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 725, the "Indians Arts and Crafts Amendments Act," provides additional funding and training for tribal law enforcement officers; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; H.R. 6235/S. 3972, the "National Blue Alert," legislation creating an anlert system for law enforcement officers killed or seriously injured in the line of duty; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office
2010 · fourth_quarter · Pharmacy
S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2010 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 Under Line 17: We would like to include the Office of National Drug Control Policy (ONDCP) HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act S 80 - Pharmaceutical Market Access Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FRL-9197-7) EPA Best Management Practices for Unused Pharmaceuticals at Health Care Facilities (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA-338) Schedules of Controlled Substances: Placement of Propofol Into Schedule IV; Proposed Rule (Docket Number: FDA-2010-N-0273) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Quality System Regulations (Docket No. FDA-2010-N-0344) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices and Radiation-Emitting Products (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: FDA-2010-N-0477) Approval Pathway for Biosimilar and Interchangeable Biological Products; Public Hearing; Request for Comments (Docket Number: FDA2010N0486) Safe Use Initiative; Public Workshop; Request for Comments (RIN 0720AB45) DoD Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies FDA Draft Guidance for Industry and Food and Drug Administration Staff on Dear Health Care Provider Letters: Improving Communication of Important Safety Information Concept Standardizing REMS programs, components and development of a potential tiered REMS System Concept 2010 National Drug Control Strategy (ONDCP)
Client expense: $240,240 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE, White House Office
2010 · fourth_quarter · Pharmacy
Importation of prescription drugs (S. 525/H.R. 1298); Drug Safety Enhancement Act (H.R. 6543); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710)
Client expense: $214,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
FY 2011 Commerce, Justice, Science Appropriations, COPS enhancement authorization bill (H.R. 1139 and S. 167), National Criminal Justice Commission Act (S. 714), drug enforcement on Federal lands bill (H.R. 5645), anti-methamphetamine bill (S. 256)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Pharmacy
H.R.3590, Patient Protection and Affordable Care Act H.R.4872, Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act S.1232, Pharmaceutical Market Access and Drug Safety Act H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R.2221, Data Accountability and rust Act, as related to provider privacy requirements. H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. H.R.5136, National Defense Authorization Act for Fiscal Year 2011. S.3454, National Defense Authorization Act for Fiscal Year 2011. H.R.5235, Medicare Access to Diabetes Supplies Act. S.80, Pharmaceutical Market Access Act of 2009. S.511, Access to Durable Medical Equipment Act. S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 415, the "Fallen Heros Flag Act," would provide the families of deceased public safety officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 725, the "Indians Arts and Crafts Amendments Act," provides additional funding and training for tribal law enforcement officers; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; H.R. 6235, the "National Blue Alert," legislation creating an anlert system for law enforcement officers killed or seriously injured in the line of duty; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office
2010 · third_quarter · Bankruptcy
Draft bankruptcy technical corrections bill proposing partial repeal of bankruptcy attorney liability provisions contained in Sections 102, 203(a), and 226-229 of P.L. 109-8 (formerly S. 256), Bankruptcy Abuse Prevention and Consumer Protection Act of 2005, to add a new partnership section to the Bankruptcy Code, and to make certain technical amendments to Section 363(f) of the Code regarding certain sales of real property Support amendments to the Bankruptcy Code to protect the interests of lessees when property is sold free and clear of interests H.R. 6198, Bankruptcy Technical Corrections Act
Client expense: $260,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Deposit Insurance Corporation (FDIC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Legal Services Corporation, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2010 · third_quarter · Alcohol and Drug Abuse
HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals
Client expense: $736,734 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Office of Natl Drug Control Policy (NDCP), SENATE
H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA
Client expense: $1,842,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · third_quarter · Pharmacy
H.R.3590, Patient Protection and Affordable Care Act H.R.4872, Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act S.1232, Pharmaceutical Market Access and Drug Safety Act H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R.2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. H.R.5136, National Defense Authorization Act for Fiscal Year 2011. S.3454, National Defense Authorization Act for Fiscal Year 2011. H.R.5235, Medicare Access to Diabetes Supplies Act. S.80, Pharmaceutical Market ccess Act of 2009. S.511, Access to Durable Medical Equipment Act S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.
Client expense: $400,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Pharmacy
HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies DEA National Drug Take-Back Day Concept Standardizing REMS programs, components and development of a potential tiered REMS System
Client expense: $212,859 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2010 · third_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923)) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal (S. 3397, H.R. 5809) PDMP Funding/NASPER reauthorization (H.R. 5710)
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Law Enforcement/Crime/Criminal Justice
FY 2011 Commerce, Justice, Science Appropriations, COPS enhancement authorization bill (H.R. 1139 and S. 167), National Criminal Justice Commission Act (S. 714), drug enforcement on Federal lands bill (H.R. 5645), anti-methamphetamine bill (S. 256)
Client expense: Not reported · Firm income: $20,000
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Pharmacy
Importation of prescription drugs (S. 525/H.R. 1298); House Energy and Commerce Committee discussion draft; Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710)
Client expense: $270,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Methamphetamine/Pseudoephedrine Regulation (S. 256) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Bankruptcy
Draft bankruptcy technical corrections bill proposing partial repeal of bankruptcy attorney liability provisions contained in Sections 102, 203(a), and 226-229 of P.L. 109-8 (formerly S. 256), Bankruptcy Abuse Prevention and Consumer Protection Act of 2005, to add a new partnership section to the Bankruptcy Code, and to make certain technical amendments to Section 363(f) of the Code regarding certain sales of real property Support amendments to the Bankruptcy Code to protect the interests of lessees when property is sold free and clear of interests
Client expense: $320,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Legal Services Corporation, Library of Congress (LOC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2010 · second_quarter · Pharmacy
H.R. 1359 Secure and Responsible Drug Disposal Act of 2009; H.R. 1191 Safe Drug Disposal Act of 2009; H.R.1259 Dextromethorphan Distribution Act of 2009; S. 1383 Dextromethorphan Abuse Reduction Act of 2009; S. 256 Combat Methamphetamine Enhancement Act of 2009
Client expense: $1,079,067 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA
Client expense: $1,616,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · second_quarter · Pharmacy
HR 1204 - The Community Pharmacy Fairness Act of 2009 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 SRes 539 - A resolution designating May 24, 2010, as "Prescription Drug Disposal Awareness Day S 256 - Combat Methamphetamine Enhancement Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Drug Safety and Risk Management Advisory Committee; Notice of Meeting (Docket Number: FDA-2009-N-0247) FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration; Availability (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA2009D0461) FDA Draft Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all pharmacy-based communications (Docket Number: FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number: FDA-2010-N-0001) Pharmaceutical Supply Chain; Public Workshop (Docket Number: DEA-218I) Electronic Prescriptions for Controlled Substances; Final Rule (Docket Number: FDA-2009-N-0582) Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner (Docket Number: FDA-2010-N-0136) Request for Comment on Implementation of the Family Smoking Prevention and Tobacco Control Act (Docket Number: DEA-328P) Implementation of the Methamphetamine Production Prevention Act of 2008 (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting (Opioid REMS) (Docket Number: FDA-2010-N-0284, FDA-2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting (Docket Number: FDA-2009-D-0001) Guidance for Industry on Standards for Securing the Drug Supply Chain--Standardized Numerical Identification for Prescription Drug Packages; Availability ONDCPs 2010 National Drug Control Policy FDA Safe Use Initiative Concept - Reauthorization of Prescription Drug User Fee Act Concept - DEA Agent of the Prescriber Concept - Oppose Liberalizing Prescription Drug Importation
Client expense: $151,510 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2010 · second_quarter · Pharmacy
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Reconciliation Act of 2010 H.R. 616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R. 3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparancy, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S. 3532, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010.
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Alcohol and Drug Abuse
HR 1259 & S 1383 - Dextromethorphan Abuse S. 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals
Client expense: $1,687,444 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
2010 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office
2010 · second_quarter · Pharmacy
Importation of prescription drugs (S.525/H.R. 1298); Import Safety (H.R. 759); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues - (H.R. 4489); Drug Disposal
Client expense: $220,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · first_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office
2010 · first_quarter · Pharmacy
S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act S 256 - Combat Methamphetamine Enhancement Act of 2009 HR 1706 - Protecting Consumer Access to Generic Drugs Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps HR 1204 - The Community Pharmacy Fairness Act of 2009 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 163 - Prescription Drug Affordability Act (Docket Number FDA2009D0461) FDA Draft Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications (Docket Number FDA2008N0038) Risk Communication Advisory Committee; Notice of Meeting on the types of communications that patients receive at the pharmacy including: medication guides; patients package inserts; and consumer medication information (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all pharmacy-based communications (Docket Number: FDA2009N0295) Providing Effective Information to Consumers About Prescription Drug Risks and Benefits; Public Workshop (Docket Number: FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number: FDA2009N0247) Food and Drug Administration Transparency Task Force; Request for Comments (Docket Number: DEA321) Identification of Institution-based Individual Practitioners (Docket Number: FDA-2009-D-0001) Guidance for Industry on Standards for Securing the Drug Supply Chain--Standardized Numerical Identification for Prescription Drug Packages; Availability (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Public Meeting (Docket Number: DEA-218I) Electronic Prescriptions for Controlled Substances; Final Rule (Docket Number: FDA2004N0449) (formerly Docket Number: 2004N0439) Current Good Manufacturing Practice for Positron Emission Tomography Drugs Notice Regarding 340B Drug Pricing ProgramContract Pharmacy Services Concept - Medication Adherence Concept - Pharmacogenomics Concept - DEA Agent of the Prescriber Concept - Oppose Liberalizing Prescription Drug Importation
Client expense: $149,615 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2010 · first_quarter · Bankruptcy
Draft bankruptcy technical corrections bill proposing partial repeal of bankruptcy attorney liability provisions contained in Sections 102, 203(a), and 226-229 of P.L. 109-8 (formerly S. 256), Bankruptcy Abuse Prevention and Consumer Protection Act of 2005, to add a new partnership section to the Bankruptcy Code, and to make certain technical amendments to Section 363(f) of the Code regarding certain sales of real property Support amendments to the Bankruptcy Code to protect the interests of lessees when property is sold free and clear of interests
Client expense: $290,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Legal Services Corporation, Library of Congress (LOC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2010 · first_quarter · Alcohol and Drug Abuse
HR 1259 & S 1383 - Dextromethorphan Abuse S. 256 & HR 2923 - Methamphetamine Abuse
Client expense: $423,644 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA
Client expense: $2,040,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
2010 · first_quarter · Pharmacy
H.R. 1359 Secure and Responsible Drug Disposal Act of 2009; H.R. 1191 Safe Drug Disposal Act of 2009; H.R.1259 Dextromethorphan Distribution Act of 2009; S. 1383 Dextromethorphan Abuse Reduction Act of 2009; S. 256 Combat Methamphetamine Enhancement Act of 2009
Client expense: $1,046,127 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2010 · first_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S. 525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Counterfeit Drugs (H.R. 1450) Methamphetamine / Pseudoephedrine Regulation (S. 256) Dextromethorphan Regulation (H.R. 1259) Pharmacy Benefit Management Issues (H.R. 4489)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Pharmacy
H.R.3590, Patient Protection and Affordable Care Act H.R.4872: Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemptionof pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exmpetion from Medicare Part B reguations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S. 1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221 Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and dislosure requirements in the FEHBP. S. 3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds.
Client expense: $470,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2010 · first_quarter · Pharmacy
Importation of prescription drugs (S. 525/H.R. 1298), Import Safety (H.R. 759), Rx Pedigree, Counterfeit Drugs (H.R. 1450), Methamphetamine/Pseudoephedrine Regulation (S. 256), Pharmacy Benefit Management (PBM) issues (H.R. 4489)
Client expense: $190,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2009 · fourth_quarter · Bankruptcy
Draft bankruptcy technical corrections bill prepared by ABA proposing partial repeal of bankruptcy attorney liability provisions contained in Sections 102, 203(a), and 226-229 of P.L. 109-8 (formerly S. 256), Bankruptcy Abuse Prevention and Consumer Protection Act of 2005, to add a new partnership section to the Bankruptcy Code, and to make certain technical amendments to Section 363(f) of the Code regarding certain sales of real property
Client expense: $270,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Legal Services Corporation, Library of Congress (LOC), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2009 · fourth_quarter · Alcohol and Drug Abuse
HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse
Client expense: $422,034 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE
2009 · fourth_quarter · Pharmacy
S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act S 256 - Combat Methamphetamine Enhancement Act of 2009 HR 1706 - Protecting Consumer Access to Generic Drugs Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps HR 1204 - The Community Pharmacy Fairness Act of 2009 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 163 - Prescription Drug Affordability Act (Docket Number FDA2009D0461) FDA Draft Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications (Docket Number FDA2008N0038) Risk Communication Advisory Committee; Notice of Meeting on the types of communications that patients receive at the pharmacy including: medication guides; patients package inserts; and consumer medication information (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all pharmacy-based communications (Docket Number FDA2009D0181) Draft Guidance for Industry on Label Comprehension Studies for Nonprescription Drug Products; Availability (Docket Number FDA2009N0295) Providing Effective Information to Consumers About Prescription Drug Risks and Benefits; Public Workshop (Docket Number FDA1977N0013) (formerly Docket No. 1977N0094L) Organ-Specific Warnings; Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Final Monograph (Docket Number FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number FDA2006N0238) (formerly Docket No. 2006N0062) Expanded Access to Investigational Drugs for Treatment Use (Docket Number FDA2006N0237) (formerly Docket No. 2006N0061) Charging for Investigational Drugs Under an Investigational New Drug Application (Docket Number FDA2009N0247) Food and Drug Administration Transparency Task Force; Reopening of Comment Period (Docket Number DEA321) Identification of Institution-based Individual Practitioners (Docket Number FDA2009N0374) Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop; Request for Comments (Docket Number FDA2009N0441) Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools; Notice of Public Hearing (Docket Number FDA-2009-N-0138) Liver Injury Related to the Use of Acetaminophen; Joint Meeting of the Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee and the Anesthetic and Life Support Drugs Advisory Committee (DEA Information Collection 1117-0046) Self-Certification, Training and Logbooks for Regulated Sellers of Scheduled Listed Chemical Products (Docket Number FDA2008N0424) Postmarketing Safety Reporting for Combination Products (Docket Number FDA2009N0664) Risk Communication Advisory Committee; Notice of Meeting Concept - Medication Adherence Concept - Pharmacogenomics Concept - Oppose Liberalizing Prescription Drug Importation Concept - Agent of the Prescriber
Client expense: $117,517 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2009 · fourth_quarter · Pharmacy
H.R. 1359 Secure and Responsible Drug Disposal Act of 2009; H.R. 1191 Safe Drug Disposal Act of 2009; H.R. 1427/S. 726 Promoting Innovation and Access to Life-Saving Medicine Act of 2009; H.R. 1548 Pathway for Biosimilars Act of 2009; H.R.1259 Dextromethorphan Distribution Act of 2009; S. 1383 Dextromethorphan Abuse Reduction Act of 2009; S. 256 Combat Methamphetamine Enhancement Act of 2009
Client expense: $824,821 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2009 · fourth_quarter · Health Issues
HR 186, Glaucoma Screening Act of 2009, all provisions HR 228, VA to establish a scholarship program for students, all provisions HR 577, Vision Care for Kids Act of 2009, all provisions. HR 1402, Catalyst to Better Diabetes Care Act of 2009, all provisions. HR 1884, National Health Service Corps Improvement Act, all provisions. HR 2350, Preserving Patient Access to Primary Care Act of 2009, all provisions. HR 2697, Optometric Equity in Medicaid Act of 2009, all provisions HR 3293, Department of Education Appropriations Act, 2010, all provisions. HR 3326, Department of Defense Appropriations Act, 2010, all provisions. HR 3590 Service Members Home Ownership Tax Act of 2009, all provisions. HR 3961 Medicare Physician Payment Reform Act of 2009, all provisions. HR 3962 Affordable Health Care for America Act, all provisions. HR 4371, To amend title XVIII of the Social Security Act , all provisions S 256, Combat Methamphetamine Enhancement Act of 2009, all provisions.
Client expense: $446,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Vaccines for Children Program Vaccines for Adults Coverage Provide Medicare Part B Coverage for Vaccines Currenlty Under Part D Medicaid Coverage of Vaccines HR 3200 America's Affordable Health Choices Act of 2009 HR 2502 Comparative Effectiveness Research Act of 2009 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension
Client expense: $1,570,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)
2009 · fourth_quarter · Pharmacy
H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2221, Data Accountability and Trust Act, related to the use of prescription drug data by pharmacies. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. 3108, the Medication Therapy Management Benefits Act, as related to an expanded MTM program in the Medicare Part D program. H.R. 3200, America's Affordable Health Choices Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. H.R. 3590, Patient Protection and Affordable Care Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME Program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. S.1383, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2009 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695 (Murphy, D-CT), the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.
Client expense: $55,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office